Clinical Data

Cardiometabolic trials: Using expertise to turn complexity into robust results

Pharmaceutical Technology

Discover how Nucleus Network Minneapolis delivers reliable Phase 1-2a cardiometabolic trials with AI-driven recruitment, high retention, rigorous PI oversight, and advanced imaging for decision-grade

Clinical Data Cardiovascular Read full story

pharminent April 24, 2026 (Last updated: April 25, 2026)

Pharmaceutical Technology

Discover how Nucleus Network Minneapolis delivers reliable Phase 1-2a cardiometabolic trials with AI-driven recruitment, high retention, rigorous PI oversight, and advanced imaging for decision-grade

Clinical Data Cardiovascular Read full story

Related Stories

Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data

ADC Therapeutics slumps on cancer drug safety scare

Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity

You May Have Missed

Lilly and Novo face off at ADA 2026 as others seek to compete in obesity

Medicare Advantage in 2026: Enrollment Update and Key Trends

The next FDA commissioner must be a champion for gene therapies

Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data